Dexcom G7 sensors
Ended Awarded Last action
- Contract number
- SPE2DR26FV465
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,316
Award facts
- Contract value 100% obligated
- $10,316.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,316.43 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was awarded without set-aside designation through a competitively-awarded delivery order process. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor vehicle valued at up to $999.999 billion through December 2026. This IDC enables the company to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs globally. The Dexcom G7 sensor delivery supports federal medical supply requirements for continuous glucose monitoring, facilitating diabetes management across Defense Health Agency and U.S. military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FV465?
SPE2DR26FV465 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FV465 worth?
The government has obligated $10,316 on SPE2DR26FV465.
Is contract SPE2DR26FV465 an order under another contract?
Yes. SPE2DR26FV465 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV465 competed?
The extent of competition for SPE2DR26FV465 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award